Distribution parallels distribution of all biotechnology companies with main states being Victoria then New South Wales. Western Australia has disproportionately more than Queensland which suggests that they may be more fragile.
Major Sector is Human Health followed by Equipment and Services then daylight
Most companies established at turn of century or in recent years
27% of companies valued less than $20 million and 39% less than $40 million
33% of companies are less than $20 million and 47% less than $40 million with NextScience and Percheron less than cash holding
50% of companies turn over less than $2 million and 61% turn over less than $5 million